Efficacy and safety of once‐daily insulin degludec/insulin aspart compared with once‐daily insulin glargine in participants with Type 2 diabetes: a randomized, treat‐to‐target stud...

por Kumar, S., Jang, H. C., Demirağ, N. G., Skjøth, T. V., Endahl, L., Bode, B.
Publicado 2016